APPLICATION OF ROSUVASTATIN (ZD-4522) IN TREATING HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA Russian patent published in 2007 - IPC A61K31/505 A61P3/06 

Abstract RU 2294744 C2

FIELD: medicine.

SUBSTANCE: the suggested innovation deals with introducing the compound (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine-5-yl](3R,5S)-3.5-dihydroxy-hept-6-enic acid (rosuvastatin) or its pharmaceutically acceptable salt that enables to achieve curative effect of applying rosuvastatin only.

EFFECT: higher efficiency of application.

20 cl, 1 dwg, 3 ex, 1 tbl

Similar patents RU2294744C2

Title Year Author Number
APPLICATION OF 3-HYDROXY-3-METHTYLGLUTARYL-COENZYME A REDUCTASE INHIBITORS IN PRODUCING MEDICINAL AGENT FOR TREATMENT OF DIABETIC NEUROPATHY 2000
  • Kehmeron Norman Judzhin
  • Kotter Mehri Ehnn
RU2239456C2
METHODS OF TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH) 2015
  • Baccara-Dinet, Marie
  • Hanotin, Corinne
  • Bessac, Laurence
  • Chaudhari, Umesh
  • Pordy, Robert
  • Sasiela, William
  • Schwemmer Gipe, Daniel, A.
RU2735521C2
MEDICINAL COMBINATION COMPRISING (E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO]PYRIMIDINE-5-YL]-(3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID AND INHIBITOR, INDUCTOR OR SUBSTRATE FOR P-450 3A4 ISOZYME 2000
  • Raza Ali
  • Pirs Dzhon Stjuart
  • Khatchinson Khauard Dzherard
  • Shnek Dennis
  • Baba Takakhiko
  • Touti Akira
  • Jamaguti Jositaka
RU2233162C2
HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS 2012
  • Anoten Korinn
  • Bessak Lorans
  • Chaudkhari Umesh
RU2603481C2
METHODS OF TREATING PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR DISEASES HAVING HYPERCHOLESTEROLEMIA 2015
  • Hanotin, Corinne
  • Bessac, Laurence
  • Chaudhari, Umesh
  • Pordy, Robert
  • Schwemmer Gipe, Daniel, A.
RU2723018C2
PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIBODIES TO HUMAN PCSK9 2012
  • Anoten Korinn
  • Bessak Lorans
  • Chaudkhari Umesh
RU2604139C2
FIXED COMBINATIONS AND COMPOUNDS CONTAINING ETC-1002 AND EZETIMIBE, AND METHOD FOR TREATING OR REDUCING THE RISK OF DEVELOPING A CARDIOVASCULAR DISEASE 2016
  • Newton, Roger Schofield
  • Rosenberg, Noah Laban
  • Macdougall, Diane Elaine
RU2766085C2
FIXED COMBINATIONS AND COMPOSITIONS CONTAINING ETC1002 AND ONE OR MORE STATINS, AND METHODS FOR TREATMENT OR REDUCTION IN RISK OF DEVELOPMENT OF CARDIOVASCULAR DISEASE 2016
  • Newton, Roger Schofield
  • Rosenberg, Noah Laban
  • Macdougall, Diane Elaine
RU2765218C2
CRYSTALLINE FORM OF CALCIUM SALT OF BIS-[(E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULPHONYL)AMINO]-PYRIMIDIN-5-YL](3R, 5S)-3, 5-DIHYDROXYHEPT-6-ENOIC ACID 2004
  • But Rebekka Dzhejn
  • Sittern Piter Ehntoni
  • Krabb Dzheffri Norman
  • Khorberi Dzhon
  • Dzhouns Dejvid Uin Kalvert
RU2363697C2
TREATING WITH ANTI-PCSK9 ANTIBODIES 2012
  • Udata Chandrasekhar
RU2576034C2

RU 2 294 744 C2

Authors

Rehjza Ali

Khatchinson Khauard Dzherard

Dates

2007-03-10Published

2001-11-16Filed